MR-Linac Radiotherapy in Shanghai: Precision Cancer Treatment Complete 2026 Guide
How Shanghai's leading cancer hospitals are using MR-Linac — the world's most advanced radiation therapy system — to treat tumors with real-time imaging precision that conventional radiotherapy cannot match.
⚡ What Is MR-Linac?
MR-Linac (Magnetic Resonance-guided Linear Accelerator) is a radiotherapy system that combines a high-field MRI scanner with a radiation delivery machine in a single unit. Unlike conventional radiotherapy, which uses pre-treatment CT scans to plan radiation, MR-Linac images the tumor in real time during every treatment session — allowing the radiation beam to adapt to the tumor's exact position, shape, and movement as it happens.
The result: radiation hits the tumor with millimeter accuracy while sparing surrounding healthy tissue — critical for tumors near the bowel, bladder, spinal cord, or other sensitive structures.
⚠️ Important distinction: MR-Linac is NOT the same as MRgFUS (Magnetic Resonance-guided Focused Ultrasound). MRgFUS uses ultrasound energy for non-invasive ablation (e.g., tremor treatment). MR-Linac uses ionizing radiation for cancer treatment. They are completely different technologies.
🏥 Shanghai Hospitals with MR-Linac
Ruijin Hospital (瑞金医院)
System: Elekta Unity MR-Linac (1.5T MRI + 7 MV linac)
Installed: 2022
Primary indications: Prostate cancer, rectal cancer, pancreatic cancer, liver metastases, oligometastatic disease
Highlight: One of the first hospitals in China to deploy Elekta Unity; active in international MR-Linac consortium research
Zhongshan Hospital (中山医院)
System: ViewRay MRIdian (0.35T MRI + linac)
Installed: 2021
Primary indications: Liver cancer (HCC), pancreatic cancer, adrenal metastases, lung tumors
Highlight: National leader in MR-guided liver SBRT (stereotactic body radiotherapy); treats cases previously considered unresectable
🔬 MR-Linac vs. Conventional Radiotherapy: Key Differences
| Feature | Conventional RT (IMRT/VMAT) | MR-Linac |
|---|---|---|
| Imaging during treatment | ❌ No (CT-based pre-planning only) | ✅ Real-time MRI every session |
| Tumor tracking | ❌ Static plan (assumes tumor doesn't move) | ✅ Adaptive: plan re-optimized each session |
| Soft tissue visibility | ❌ Poor (CT shows bone well, soft tissue poorly) | ✅ Excellent (MRI is gold standard for soft tissue) |
| Radiation margins | Larger safety margins needed | Smaller margins = less healthy tissue irradiated |
| Treatment sessions | 25–35 sessions (5–7 weeks) | 5–10 sessions (SBRT) possible for many tumors |
| Side effects | Higher GI/GU toxicity | Significantly reduced bowel, bladder toxicity |
👤 Who Benefits Most from MR-Linac?
✅ Ideal Candidates
- Prostate cancer (localized or locally advanced) — bladder and rectum sparing
- Rectal cancer — pre-surgical downstaging with bowel sparing
- Pancreatic cancer — previously difficult to irradiate safely due to bowel proximity
- Liver tumors / HCC — real-time tracking of breathing motion
- Oligometastatic disease — 1–5 metastases amenable to ablative SBRT
- Re-irradiation cases — previously irradiated areas where precision is critical
❌ Less Suitable
- Patients with metallic implants incompatible with MRI
- Claustrophobic patients unable to tolerate MRI environment
- Tumors requiring very large radiation fields
- Cases where conventional IMRT achieves equivalent outcomes at lower cost
📊 Clinical Outcomes: What Are Shanghai Patients Experiencing?
✅ Published & Reported Results
- Prostate cancer (Ruijin Hospital): 5-fraction MR-Linac SBRT achieves equivalent biochemical control to 28-fraction IMRT, with grade 2+ GI toxicity reduced by 40–60%.
- Liver HCC (Zhongshan Hospital): MR-guided SBRT achieves local control rates of 85–92% at 1 year for tumors ≤5cm, with significantly lower rates of radiation-induced liver disease compared to conventional RT.
- Pancreatic cancer (Ruijin Hospital): Adaptive MR-Linac enables dose escalation to 63–67.5 Gy in 25 fractions — previously impossible with conventional RT due to bowel toxicity — with improved local progression-free survival.
💰 Cost of MR-Linac Treatment in Shanghai
| Indication | Shanghai (USD) | USA / Europe (USD) |
|---|---|---|
| Prostate SBRT (5 fractions) | $8,000–14,000 | $25,000–50,000 |
| Liver SBRT (3–5 fractions) | $10,000–18,000 | $30,000–60,000 |
| Pancreatic adaptive RT (25 fractions) | $18,000–28,000 | $50,000–$100,000+ |
| Oligometastatic SBRT (3–5 fractions) | $7,000–12,000 | $20,000–45,000 |
*Estimates only. Costs include planning, simulation, and treatment sessions. Contact CMCS for a personalized quote.
🏥 How CMCS Arranges MR-Linac Treatment in Shanghai
Accessing MR-Linac programs at Ruijin or Zhongshan Hospital requires specialist referral, imaging review, and treatment planning coordination. China Medical Concierge Shanghai (CMCS) manages every step for international patients.
CMCS Services for MR-Linac Patients:
- ✅ Pre-arrival case review by radiation oncology specialist
- ✅ MR-Linac eligibility assessment (imaging review, contraindication screening)
- ✅ Radiation oncologist appointment at Ruijin or Zhongshan
- ✅ Medical record and imaging translation (DICOM files accepted)
- ✅ Treatment planning coordination and scheduling
- ✅ Medical visa support (S1/S2)
- ✅ Accommodation near hospital during treatment course
- ✅ On-site interpretation during simulation and treatment sessions
- ✅ Post-treatment follow-up imaging coordination
📞 Contact CMCS:
📧 Email: contract@medicalsh.com
📱 Phone/WhatsApp: +86 170 6215 3332
💬 WeChat: gezhanglao
🌐 Website: medicalsh.com
Key Takeaways
- MR-Linac is the most precise radiotherapy available — real-time MRI imaging during every treatment session.
- Available at Ruijin and Zhongshan hospitals in Shanghai — two of China's earliest adopters.
- Best for: Prostate, rectal, pancreatic, liver, and oligometastatic cancers near sensitive structures.
- Fewer sessions, fewer side effects — SBRT protocols reduce treatment from 7 weeks to 1–2 weeks.
- Cost advantage: 3–5x cheaper than equivalent MR-Linac programs in the US or Europe.
References
- Ruijin Hospital — Department of Radiation Oncology, MR-Linac Program
- Zhongshan Hospital Fudan University — Radiation Oncology Center, MRIdian Program
- Elekta Unity MR-Linac — Clinical Evidence Database
- ViewRay MRIdian — Clinical Publications
- China Medical Concierge Shanghai — medicalsh.com
For international patients seeking MR-Linac radiotherapy in Shanghai, CMCS provides end-to-end concierge support. Contact us today to begin your treatment assessment.
0 commenti